Your browser doesn't support javascript.
loading
C-H Functionalization of Heteroarenes Using Unactivated Alkyl Halides through Visible-Light Photoredox Catalysis under Basic Conditions.
Bissonnette, Noah B; Boyd, Michael J; May, Gregory D; Giroux, Simon; Nuhant, Philippe.
Afiliação
  • Bissonnette NB; Vertex Pharmaceuticals Inc. , 50 Northern Avenue , Boston , Massachusetts 02210 , United States.
  • Boyd MJ; Vertex Pharmaceuticals Inc. , 50 Northern Avenue , Boston , Massachusetts 02210 , United States.
  • May GD; Vertex Pharmaceuticals Inc. , 50 Northern Avenue , Boston , Massachusetts 02210 , United States.
  • Giroux S; Vertex Pharmaceuticals Inc. , 50 Northern Avenue , Boston , Massachusetts 02210 , United States.
  • Nuhant P; Vertex Pharmaceuticals Inc. , 50 Northern Avenue , Boston , Massachusetts 02210 , United States.
J Org Chem ; 83(18): 10933-10940, 2018 09 21.
Article em En | MEDLINE | ID: mdl-30092130
ABSTRACT
C-H functionalization of electron-deficient heteroarenes using commercial unactivated alkyl halides through reductive quenching photoredox catalysis was developed. Mainstream approaches rely on the use of an excess of strong acids that result in regioselectivities dictated by the innate effect of the protonated heteroarene, leaving the functionalization of other carbons unexplored. We report a mild method under basic conditions that allows access to previously underexplored regioselectivities by relying on a combination of conjugate and halogen  ortho-directing effects. Overall, this methodology gives quick access to a variety of alkylated heteroarenes that will be of interest to medicinal chemistry programs.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article